AI assistant
Merck & Co., Inc. — Director's Dealing 2023
Jan 25, 2023
284_dirs_2023-01-25_c978ffd3-0bdf-43f2-9847-086a74e41488.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-01-23
Reporting Person: Chattopadhyay Sanat (Exe V-P & Pres. MMD)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-23 | Common Stock | A | 17495 | $109.88 | Acquired | 46995 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 37873 | Indirect |
| Common Stock | 45608 | Indirect |
Footnotes
F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/20. Performance shares were paid out at 110 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2022.
F2: The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2021 Grantor Retained Annuity Trust.
F3: The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay 2022 Grantor Retained Annuity Trust.